Literature DB >> 31501274

GATA2 and PU.1 Collaborate To Activate the Expression of the Mouse Ms4a2 Gene, Encoding FcεRIβ, through Distinct Mechanisms.

Shin'ya Ohmori1, Yasushi Ishijima2, Suzuka Numata1, Mai Takahashi1, Masataka Sekita1, Taichi Sato1, Keisuke Chugun1, Masayuki Yamamoto3, Kinuko Ohneda4.   

Abstract

GATA factors GATA1 and GATA2 and ETS factor PU.1 are known to function antagonistically during hematopoietic development. In mouse mast cells, however, these factors are coexpressed and activate the expression of the Ms4a2 gene encoding the β chain of the high-affinity IgE receptor (FcεRI). The present study showed that these factors cooperatively regulate Ms4a2 gene expression through distinct mechanisms. Although GATA2 and PU.1 contributed almost equally to Ms4a2 gene expression, gene ablation experiments revealed that simultaneous knockdown of both factors showed neither a synergistic nor an additive effect. A chromatin immunoprecipitation analysis showed that they shared DNA binding to the +10.4-kbp region downstream of the Ms4a2 gene with chromatin looping factor LDB1, whereas the proximal -60-bp region was exclusively bound by GATA2 in a mast cell-specific manner. Ablation of PU.1 significantly reduced the level of GATA2 binding to both the +10.4-kbp and -60-bp regions. Surprisingly, the deletion of the +10.4-kbp region by genome editing completely abolished the Ms4a2 gene expression as well as the cell surface expression of FcεRI. These results suggest that PU.1 and LDB1 play central roles in the formation of active chromatin structure whereas GATA2 directly activates the Ms4a2 promoter.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  GATA transcription factors; high-affinity IgE receptor; mast cell; transcriptional regulation

Mesh:

Substances:

Year:  2019        PMID: 31501274      PMCID: PMC6817753          DOI: 10.1128/MCB.00314-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

2.  GATA-1 is required for expression of Fc{epsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow.

Authors:  Chiharu Nishiyama; Tomonobu Ito; Makoto Nishiyama; Shigehiro Masaki; Keiko Maeda; Nobuhiro Nakano; William Ng; Kanako Fukuyama; Masayuki Yamamoto; Ko Okumura; Hideoki Ogawa
Journal:  Int Immunol       Date:  2005-06-20       Impact factor: 4.823

3.  Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.

Authors:  Yojiro Arinobu; Shin-ichi Mizuno; Yong Chong; Hirokazu Shigematsu; Tadafumi Iino; Hiromi Iwasaki; Thomas Graf; Robin Mayfield; Susan Chan; Philippe Kastner; Koichi Akashi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

4.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  Involvement of PU.1 in mast cell/basophil-specific function of the human IL1RL1/ST2 promoter.

Authors:  Yosuke Baba; Keiko Maeda; Takuya Yashiro; Eisuke Inage; François Niyonsaba; Mutsuko Hara; Ryuyo Suzuki; Yoshikazu Ohtsuka; Toshiaki Shimizu; Hideoki Ogawa; Ko Okumura; Chiharu Nishiyama
Journal:  Allergol Int       Date:  2012-07-25       Impact factor: 5.836

6.  Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.

Authors:  Eisuke Inage; Kazumi Kasakura; Takuya Yashiro; Ryuyo Suzuki; Yosuke Baba; Nobuhiro Nakano; Mutsuko Hara; Atsushi Tanabe; Keisuke Oboki; Kenji Matsumoto; Hirohisa Saito; François Niyonsaba; Yoshikazu Ohtsuka; Hideoki Ogawa; Ko Okumura; Toshiaki Shimizu; Chiharu Nishiyama
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

7.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

8.  Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells.

Authors:  Takashi Hiroyama; Kenichi Miharada; Kazuhiro Sudo; Inaho Danjo; Naoko Aoki; Yukio Nakamura
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

9.  Role of LDB1 in the transition from chromatin looping to transcription activation.

Authors:  Ivan Krivega; Ryan K Dale; Ann Dean
Journal:  Genes Dev       Date:  2014-05-29       Impact factor: 11.361

10.  The effect of PU.1 knockdown on gene expression and function of mast cells.

Authors:  Yoshihito Oda; Kazumi Kasakura; Izumi Fujigaki; Azusa Kageyama; Ko Okumura; Hideoki Ogawa; Takuya Yashiro; Chiharu Nishiyama
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

View more
  3 in total

1.  Gata2 heterozygous mutant mice exhibit reduced inflammatory responses and impaired bacterial clearance.

Authors:  Jun Takai; Takashi Shimada; Tadaho Nakamura; James Douglas Engel; Takashi Moriguchi
Journal:  iScience       Date:  2021-07-29

Review 2.  Transcription Factors in the Development and Pro-Allergic Function of Mast Cells.

Authors:  Mansi Srivastava; Mark H Kaplan
Journal:  Front Allergy       Date:  2021-06-07

3.  The Il6 -39 kb enhancer containing clustered GATA2- and PU.1-binding sites is essential for Il6 expression in murine mast cells.

Authors:  Shin'ya Ohmori; Jun Takai; Satoshi Uemura; Akihito Otsuki; Tetsuya Mori; Kinuko Ohneda; Takashi Moriguchi
Journal:  iScience       Date:  2022-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.